UPDATE: Elevance Health shares tick up on better-than-expected earnings
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market trading Thursday. Shares of Elevance gained more than 4% to $408 a share before the bell.
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns.
Elevance Health: Q4 Earnings Snapshot
For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per share.
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums
Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% year over year.
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
Shares of Elevance Health Inc. climbed over 2.5% on Thursday morning, hitting levels last seen in early December. The rise came as the health insurer reported better-than-expected fourth-quarter results and provided an upbeat outlook for 2025.
Elevance sends Medicaid insurers higher after Q4 revenue beat
Centene (CNC) and Molina Healthcare (MOH) were among the notable gainers in the premarket on Thursday after their rival in the Medicaid space, Elevance Health (NYSE:ELV), reported better-than-expected revenue for Q4 2024.
Elevance Health Raises Quarterly Dividend by 4.9% to $1.71
Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an annual ...
Benefits Pro6h
Elevance is glad it raised commercial health insurance prices for 2025
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
Elevance Health 2024 Profits Hit $6 Billion Despite Rising Costs
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...
Modern Healthcare10h
Elevance Health expects high Medicaid costs to drop in 2025
Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond ...
Healthcare Dive10h
Elevance’s fourth-quarter profit slashed in half amid higher Medicaid costs
Elevance CEO Gail Boudreaux didn’t address the killing of UnitedHealthcare’s CEO directly on Thursday, but spent more time than usual arguing the insurer is working to improve healthcare.
2ELV : Elevance Health's Options: A Look at What the Big Money is Thinking
Delving into the details, we found 50% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $248,785, and 4 were calls, valued ...